CompletedPhase 2NCT00134004
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Principal Investigator
- Ephraim J. Fuchs, MDSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Intervention
- cyclophosphamide(drug)
- Enrollment
- 210 enrolled
- Eligibility
- 74 years · All sexes
- Timeline
- 2004 – 2015
Study locations (3)
- Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
- Hahnemann University Hospital, Philadelphia, Pennsylvania, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00134004 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.